Acrivon Therapeutics Insider Trades

ACRV

Track insider trading activity from Acrivon Therapeutics executives and directors. See which insiders are buying and selling ACRV stock.

Trades Last 12 Months

All Insider Trades for Acrivon Therapeutics

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Holding Value $43.2k 20,275 shares
Last Trade
Jun 17, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$30.8k 20,275 shares
$1.52
$2.13
Di Rocco Derek Director
Holding Value $43.2k 20,275 shares
Last Trade
Jun 17, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$30.8k 20,275 shares
$1.52
$2.13
Holding Value $43.2k 20,275 shares
Last Trade
Jun 17, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$30.8k 20,275 shares
$1.52
$2.13
Palani Santhosh Director
Holding Value $43.2k 20,275 shares
Last Trade
Jun 17, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$30.8k 20,275 shares
$1.52
$2.13
Shacham Sharon Director
Holding Value $43.2k 20,275 shares
Last Trade
Jun 17, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$30.8k 20,275 shares
$1.52
$2.13
Baum Charles M Director
Holding Value $43.2k 20,275 shares
Last Trade
Jun 17, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$30.8k 20,275 shares
$1.52
$2.13
Holding Value $43.2k 20,275 shares
Last Trade
Jun 17, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$30.8k 20,275 shares
$1.52
$2.13
Blume Jensen Peter President And CEO
Holding Value $4.78M 2,245,317 shares
Last Trade
May 21, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$24.6k 13,729 shares
$1.79
$2.13
Baum Charles M Director
Holding Value $19.9k 9,366 shares
Last Trade
May 18, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$15.5k 9,366 shares
$1.65
$2.13
Blume Jensen Peter President And CEO
Holding Value $4.81M 2,259,046 shares
Last Trade
May 18, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$297k 180,095 shares
$1.65
$2.13
Devroe Eric Chief Operating Officer
Holding Value $313k 146,953 shares
Last Trade
May 18, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$120k 72,981 shares
$1.65
$2.13
Di Rocco Derek Director
Holding Value $19.9k 9,366 shares
Last Trade
May 18, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$15.5k 9,366 shares
$1.65
$2.13
Gamelin Erick Chief Development Officer
Holding Value $113k 52,992 shares
Last Trade
May 18, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$63.7k 38,584 shares
$1.65
$2.13
Levy Adam D. Chief Financial Officer
Holding Value $143k 67,150 shares
Last Trade
May 18, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$76.2k 46,167 shares
$1.65
$2.13
Holding Value $19.9k 9,366 shares
Last Trade
May 18, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$15.5k 9,366 shares
$1.65
$2.13
Miller Mary Chief Legal Officer
Holding Value $176k 82,767 shares
Last Trade
May 18, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$82.2k 49,830 shares
$1.65
$2.13
Mirza Mansoor Raza Chief Medical Officer
Holding Value $82.7k 38,817 shares
Last Trade
May 18, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$64k 38,817 shares
$1.65
$2.13
Peterson Katharine Chief Accounting Officer
Holding Value $38.6k 18,134 shares
Last Trade
May 18, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$23.5k 14,227 shares
$1.65
$2.13
Holding Value $19.9k 9,366 shares
Last Trade
May 18, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$15.5k 9,366 shares
$1.65
$2.13
Holding Value $19.9k 9,366 shares
Last Trade
May 18, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$15.5k 9,366 shares
$1.65
$2.13

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up